Hortons Pharmacy
Hortons Pharmacy
  • News
By Hortons Pharmacy on Oct 28, 2025

Rentschler Biopharma Builds New Production Facility in Germany

  • News
By Hortons Pharmacy on Oct 27, 2025Oct 27, 2025

New Study Shows Promise in Treating Menopause Symptoms

  • News
By Hortons Pharmacy on Aug 19, 2025

Eli Lilly to Invest $1.3 Billion in New Drug Discovery

  • Uncategorized
Hortons Pharmacy

Emalex is seeking approval from the FDA for a new treatment for Tourette syndrome after successful results in their Phase III clinical trials. This means they are one step closer to making the treatment available to the public. Some medications often used for Tourette syndrome include haloperidol and pimozide, but the name of Emalex’s specific drug wasn’t mentioned in your text.

Mar 06, 2025
  • Uncategorized
Hortons Pharmacy

Eikon, a company focused on cancer treatments, has raised nearly $351 million to help develop and test its cancer drugs in clinical trials. However, the specific names of the drugs are not mentioned in the text provided.

Mar 03, 2025
  • Uncategorized
Hortons Pharmacy

Eli Lilly is planning to increase its pharmaceutical production in the United States by building four new facilities. This expansion could involve the production of well-known medications like Trulicity and Jardiance.

Feb 28, 2025
  • Uncategorized
Hortons Pharmacy

The FDA has given fast track status to Pyxis’ drug, PYX-201. This means the approval process for PYX-201 will be sped up because it shows promise in treating a serious condition. However, the text does not mention any specific pill names related to PYX-201.

Feb 25, 2025
  • Uncategorized
Hortons Pharmacy

Regeneron is trying again to get approval for its blood cancer treatment. If possible, please include the names of some medications in the explanation.

Feb 22, 2025
  • News
Hortons Pharmacy

How pharmaceutical companies can use print materials to stay flexible and competitive.

Dec 04, 2024Dec 20, 2024
  • News
Hortons Pharmacy

Astellas, a pharmaceutical company, disagrees with European authorities about their drug, Izervay, which is used to treat a condition called geographic atrophy.

Dec 04, 2024Dec 20, 2024
  • News
Hortons Pharmacy

“5 Important FDA Decisions to Look Out for in the Last Quarter of the Year”

Dec 01, 2024Dec 20, 2024
  • News
Hortons Pharmacy

After a previous unsuccessful trial, EyePoint’s drug Duravyu shows promising results in treating diabetic macular edema (DME).

Dec 01, 2024Dec 20, 2024
  • News
Hortons Pharmacy

Pharmaceutical companies are quickly working to develop a new weight-loss drug similar to Wegovy. Here are some important studies on obesity treatments to keep an eye on.

Nov 28, 2024Dec 20, 2024
Previous Page 1 of 5 … Page 3 of 5 … Page 5 of 5 Next
View Desktop Version